Works by Li, Yumeng


Results: 156
    1
    2
    3
    4
    5
    6
    7
    8

    Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2023, v. 80, n. 12, p. 1344, doi. 10.1001/jamaneurol.2023.3861
    By:
    • Edwards, Amanda L.;
    • Collins, Jessica A.;
    • Junge, Candice;
    • Kordasiewicz, Holly;
    • Mignon, Laurence;
    • Wu, Shuang;
    • Li, Yumeng;
    • Lin, Lin;
    • DuBois, Jonathan;
    • Hutchison, R. Matthew;
    • Ziogas, Nick;
    • Shulman, Melanie;
    • Martarello, Laurent;
    • Graham, Danielle;
    • Lane, Roger;
    • Budd Haeberlein, Samantha;
    • Beaver, John
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Exploratory evaluation of 18F‐MK‐6240 tau PET positivity in TANGO phase 2 clinical trial of gosuranemab (BIIB092) in Mild Cognitive Impairment and mild Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069287
    By:
    • Racine, Annie M;
    • Collins, Jessica A.;
    • DuBois, Jonathan M;
    • Seibyl, John;
    • Kong, Jessica;
    • Li, Yumeng;
    • O'Gorman, John;
    • Makaretz, Sara J.;
    • Jones, Stephanie;
    • Graham, Danielle;
    • Rajagovindan, Raj;
    • Shulman, Melanie;
    • Haeberlein, Samantha Budd
    Publication type:
    Article
    39
    40
    42
    43
    44
    45
    46
    47
    48
    49
    50